Episode 18: Key Considerations in Site Selection

Phase Forward
04/12/2024 13 min
Episode 18: Key Considerations in Site Selection

Listen "Episode 18: Key Considerations in Site Selection"

Descargar episodio Ver en sitio original

Episode Synopsis

This episode welcomes Faiza Tayar, a seasoned expert in site selection with over 16 years of experience in the pharmaceutical industry. Her strategic insights have significantly shaped Innovaderm's trajectory. We explore the critical aspects of site selection in clinical trials, focusing on site identification, choosing the right site, and expanding a site database. Do not miss this opportunity to gain a comprehensive understanding of this process.

More episodes of the podcast Phase Forward

Episode 37: ISF: A New Dimension in Skin Biomarkers 15/12/2025
Episode 36: Clinical Trials Across Asia 24/11/2025
Episode 35: PTCA – Speaking the Same Language: How Patient Organizations and Sponsors Can Align in Clinical Trials 29/10/2025
Episode 34: Elevating Clinical Research Associate Oversight for Quality and Impact 08/10/2025
Episode 33: Beyond Safety: The Evolving Complexity of Early Phase Studies 16/09/2025
Episode 32: Strategic Storytelling: The Role of PR in Biotech & Pharma Stakeholder Engagement 04/09/2025
Episode 31: Dos and Don'ts for Sponsors and CROs in Site Collaborations – Part 3: Payments 25/06/2025
Episode 30: Dos and Don'ts for Sponsors and CROs in Site Collaborations – Part 2: Focus on Protocol 25/06/2025
Episode 29: Dos and Don'ts for Sponsors and CROs in Site Collaborations – Part 1: Site Engagement 25/06/2025
Episode 28: What is New With ICH E6 (R3)? 11/06/2025
© 2003-2026 ZARZA | AHEAD OF OUR TIME
privacy policy
In God we trust In God we trust
PreSales Questions? Click Here
or call our toll-free line at +1-888-5002068 Miami, Florida, USA